日本語
トップページ

FY2022 Research Reports (International Joint Research Projects)

Completed Project

 
Project No. PI Project Title
K1001 John F. Tisdale Development of a small-size b-globin vector for efficient vector production and gene marking
K1002 Masato Yamamoto Development of a CD133-targeted adenoviral vector system
K1007 Jianda HU Development of novel investigational HLA-A24 restrictive cancer vaccine for multiple myeloma
K2001 Jacob Corn Development of a novel off-target detection tool for CRISPR-Cas3
K2002 Konrad Hochedlinger Modulating epigenetic regulation to promote muscle regeneration and rejuvenation
K2003 Hyeseong Cho Elucidation of mechanisms underlying eukaryotic DNA repair and transcription
K2006 Watcharin Loilome Multi-omic analysis toward an understanding of therapeutic response for a precision medicine in cholangiocarcinoma
K2007 Miguel Esteban Dissecting the molecular roadmap of in vivo reprogramming
K2009 Jiangning Song Artificial intelligence-enabled cancer diagnosis, type classification and mutation prediction by leveraging deep learning and histopathology image analysis
K2102 Leyi Wei Dual learning based generative adversarial networks for imputation of single-cell RNA-seq data
K3002 Daniel SAUTER Regulation of cellular gene expression by endogenous retroviruses in infectious and non-infectious diseases
K3004 Eicke Latz The impact of DNases on alveolar hemorrhage
K3005 Omar Abdel-Wahab Clonal hematopoiesis and a variety of related disorders in the aged population
     
     

Continuing Project

 
Project No. PI Project Title
K22-1039 Yan Xiyun Ferritin nanocaged doxorubicin for targeted hepatocellular carcinoma therapy
K22-1040 允文 Reconstruction of human liver in Fah–/–Rag2–/–IL2rg–/– rats with hiPSC derived liver organoids
K22-1041 DUPREZ Estelle Inflammation, hematopoietic aging, and clonal drift: deciphering the role of the transcription factor PLZF
K22-1059 COQ Jacques-Olivier Mesenchymal Stromal Cell Therapy to Prevent Neurodevelopmental Disorders related to Low-Birth-Weight
K22-1072 Passegue Emmanuelle Development of novel therapeutics targeting hematopoietic stem cell (HSC) aging
K22-1073 Wilkinson Adam Hematopoietic stem cell rejuvenation therapies
K22-2043 Patrick Tan Understanding of epigenetic heterogeneity in intractable cancers
K22-2056 暁東 Functional polarization of tumour-associated macrophages by tumor microenvironment
K22-2057 Leonhardt Heinrich Regulation and Function of DNA methylation
K22-2103 Yeh Iwei The development of acral melanoma model and a novel early diagnostic method based on stem cell dynamics
K22-3045 Ernst Peter Development of mucosal vaccines designed for infant based on the understanding of the infantile nasopharyngeal and gut mucosal immune system
K22-3046 Leonard Warren Control of T cell and NK cell exhaustion to overcome viral infection and cancer development
K22-3058 Ginhoux Florent Investigating Putative Dendritic Cell Precursors (pre-DC) with Neutrophil Progenitor Properties
K22-3062 Tsai Catherine Harnessing the group A streptococcus pilus to develop novel universal influenza vaccines
K22-3063 Katsikis Peter Human Systems Immunology of vaccine and immunotherapy
K22-3068 Hirasawa Kensuke Programmed cell death induced by human coronavirus infection
K22-3069 Qin Zhihai To study the molecular mechanism of COVID-19 protein ORF3a to stimulate the production of cytokine in macrophages
K22-3076 Simon Anna Elucidation of mechanisms involved in tissue specific immunity during infection and vaccination
K22-3082 Mi Kaixia Analysis of the mechanisms of co-infection with Mycobacterium and HIV in human macrophage linage cells